Literature DB >> 18218829

G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.

J Robert Lane1, Ben Powney, Alan Wise, Stephen Rees, Graeme Milligan.   

Abstract

The human dopamine D(2L) receptor couples promiscuously to multiple members of the Galpha(i/o) subfamily. Despite the high homology of the D(2L) and D(3) receptors, the G protein coupling specificity of the human D(3) receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D(2L) and D(3) receptors. By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual Galpha(i)-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D(3) receptor to Galpha(o1). Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D(3) receptor when coupled to Galpha(o1) compared with the D(2L) receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein coupling specificity. The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D(2L) receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D(3)/D(2) receptor in which the equivalent region of the D(3) receptor was exchanged for this sequence. This chimera displayed D(3)-like affinity for [(3)H]spiperone and potency for agonists but gained D(2)-like ability to couple to each of Galpha(i1-3) as well as Galpha(o1).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218829     DOI: 10.1124/jpet.107.134296

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.

Authors:  Molly M McGinnis; Cody A Siciliano; Sara R Jones
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

4.  Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Authors:  Sarah-Jane Watson; Alastair J H Brown; Nicholas D Holliday
Journal:  Mol Pharmacol       Date:  2012-01-26       Impact factor: 4.436

5.  Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.

Authors:  Jennie L Conroy; R Benjamin Free; David R Sibley
Journal:  ACS Chem Neurosci       Date:  2015-02-20       Impact factor: 4.418

6.  Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.

Authors:  R Benjamin Free; Lani S Chun; Amy E Moritz; Brittney N Miller; Trevor B Doyle; Jennie L Conroy; Adrian Padron; Julie A Meade; Jingbo Xiao; Xin Hu; Andrés E Dulcey; Yang Han; Lihua Duan; Steve Titus; Melanie Bryant-Genevier; Elena Barnaeva; Marc Ferrer; Jonathan A Javitch; Thijs Beuming; Lei Shi; Noel T Southall; Juan J Marugan; David R Sibley
Journal:  Mol Pharmacol       Date:  2014-04-22       Impact factor: 4.436

7.  Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors.

Authors:  Martyn Wood; Vanessa Dubois; Dieter Scheller; Michel Gillard
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

8.  Light-dependent translocation of arrestin in rod photoreceptors is signaled through a phospholipase C cascade and requires ATP.

Authors:  Wilda Orisme; Jian Li; Tobias Goldmann; Susan Bolch; Uwe Wolfrum; W Clay Smith
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

9.  (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.

Authors:  Julie A Meade; R Benjamin Free; Nicole R Miller; Lani S Chun; Trevor B Doyle; Amy E Moritz; Jennie L Conroy; Val J Watts; David R Sibley
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

10.  The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration.

Authors:  H Sun; E S Calipari; T J R Beveridge; S R Jones; R Chen
Journal:  Neuroscience       Date:  2015-08-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.